enVVeno Medical (NVNO) Competitors $3.41 +0.11 (+3.33%) (As of 11/22/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends NVNO vs. NSPR, VANI, BSGM, MBOT, IDXG, UTMD, OBIO, INFU, SGHT, and ARAYShould you be buying enVVeno Medical stock or one of its competitors? The main competitors of enVVeno Medical include InspireMD (NSPR), Vivani Medical (VANI), BioSig Technologies (BSGM), Microbot Medical (MBOT), Interpace Biosciences (IDXG), Utah Medical Products (UTMD), Orchestra BioMed (OBIO), InfuSystem (INFU), Sight Sciences (SGHT), and Accuray (ARAY). These companies are all part of the "medical" sector. enVVeno Medical vs. InspireMD Vivani Medical BioSig Technologies Microbot Medical Interpace Biosciences Utah Medical Products Orchestra BioMed InfuSystem Sight Sciences Accuray InspireMD (NYSE:NSPR) and enVVeno Medical (NASDAQ:NVNO) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, media sentiment, risk, earnings, valuation, institutional ownership, community ranking and dividends. Which has more risk and volatility, NSPR or NVNO? InspireMD has a beta of 0.93, indicating that its share price is 7% less volatile than the S&P 500. Comparatively, enVVeno Medical has a beta of 1.21, indicating that its share price is 21% more volatile than the S&P 500. Does the MarketBeat Community prefer NSPR or NVNO? enVVeno Medical received 153 more outperform votes than InspireMD when rated by MarketBeat users. Likewise, 62.65% of users gave enVVeno Medical an outperform vote while only 3.90% of users gave InspireMD an outperform vote. CompanyUnderperformOutperformInspireMDOutperform Votes33.90%Underperform Votes7496.10% enVVeno MedicalOutperform Votes15662.65% Underperform Votes9337.35% Which has stronger earnings & valuation, NSPR or NVNO? InspireMD has higher revenue and earnings than enVVeno Medical. InspireMD is trading at a lower price-to-earnings ratio than enVVeno Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInspireMD$6.20M11.15-$19.92M-$0.75-3.53enVVeno MedicalN/AN/A-$23.52M-$1.29-2.64 Do analysts rate NSPR or NVNO? InspireMD currently has a consensus price target of $4.50, indicating a potential upside of 69.81%. Given InspireMD's stronger consensus rating and higher probable upside, analysts clearly believe InspireMD is more favorable than enVVeno Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score InspireMD 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00enVVeno Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media refer more to NSPR or NVNO? In the previous week, InspireMD and InspireMD both had 2 articles in the media. InspireMD's average media sentiment score of 0.30 beat enVVeno Medical's score of 0.00 indicating that InspireMD is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment InspireMD 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral enVVeno Medical 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do institutionals and insiders hold more shares of NSPR or NVNO? 44.8% of InspireMD shares are held by institutional investors. Comparatively, 34.7% of enVVeno Medical shares are held by institutional investors. 29.7% of InspireMD shares are held by company insiders. Comparatively, 17.0% of enVVeno Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Is NSPR or NVNO more profitable? enVVeno Medical has a net margin of 0.00% compared to InspireMD's net margin of -413.96%. enVVeno Medical's return on equity of -48.72% beat InspireMD's return on equity.Company Net Margins Return on Equity Return on Assets InspireMD-413.96% -69.42% -57.68% enVVeno Medical N/A -48.72%-45.96% SummaryInspireMD beats enVVeno Medical on 9 of the 16 factors compared between the two stocks. Ad Weiss Ratings“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.Learn these 4 simple steps and protect your savings before it’s too late. Get enVVeno Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for NVNO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NVNO vs. The Competition Export to ExcelMetricenVVeno MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$59.80M$4.53B$5.38B$8.84BDividend YieldN/A36.79%5.13%4.09%P/E Ratio-2.6425.65102.4617.58Price / SalesN/A46.931,234.85158.43Price / CashN/A53.6240.4736.33Price / Book1.265.947.096.50Net Income-$23.52M$13.99M$119.65M$226.22M7 Day Performance3.96%3.27%2.06%3.76%1 Month Performance3.02%4.64%-2.46%4.63%1 Year Performance-13.89%47.15%33.95%29.20% enVVeno Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NVNOenVVeno Medical0.3771 of 5 stars$3.41+3.3%N/A-13.9%$59.80MN/A-2.6419NSPRInspireMD2.4472 of 5 stars$2.58-2.3%$4.50+74.4%+10.9%$67.29M$6.20M-3.4450VANIVivani Medical3.1031 of 5 stars$1.33+3.1%$3.00+125.6%+40.3%$78.79MN/A-2.9620BSGMBioSig TechnologiesN/A$1.93+3.2%N/A-36.5%$33.06M$20,000.000.0050Positive NewsMBOTMicrobot Medical1.7327 of 5 stars$0.92flat$7.00+660.9%-26.3%$15.58MN/A-1.1520Negative NewsGap UpIDXGInterpace BiosciencesN/A$2.68flatN/A+155.2%$11.79M$40.21M0.00152UTMDUtah Medical Products3.47 of 5 stars$64.57+0.6%N/A-20.8%$218.89M$50.22M15.03180Positive NewsOBIOOrchestra BioMed2.4659 of 5 stars$5.44+3.0%$15.75+189.5%-3.4%$206.77M$2.76M-3.3856INFUInfuSystem1.6914 of 5 stars$9.19+1.9%$13.00+41.5%N/A$195.38M$125.79M153.19499Gap UpSGHTSight Sciences2.4237 of 5 stars$3.76+0.8%$5.50+46.3%+60.4%$190.86M$81.06M-3.69210Gap UpARAYAccuray4.7058 of 5 stars$1.89+2.7%$9.00+377.5%-29.8%$189.57M$446.55M-10.94987Analyst RevisionNews Coverage Related Companies and Tools Related Companies NSPR Alternatives VANI Alternatives BSGM Alternatives MBOT Alternatives IDXG Alternatives UTMD Alternatives OBIO Alternatives INFU Alternatives SGHT Alternatives ARAY Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NVNO) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding enVVeno Medical Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share enVVeno Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.